Skip Navigation LinksHome > February 2011 - Volume 30 - Issue 2 > External Validation of a Risk Score to Predict Intravenous I...
Pediatric Infectious Disease Journal:
doi: 10.1097/INF.0b013e3181f386db
Original Studies

External Validation of a Risk Score to Predict Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease

Seki, Mitsuru MD*†; Kobayashi, Tohru MD*; Kobayashi, Tomio MD†; Morikawa, Akihiro MD*; Otani, Tetsuya MD‡; Takeuchi, Kazuo MD, MPH§; Ayusawa, Mamoru MD¶; Tsuchiya, Keiji MD∥; Yasuda, Kenji MD**; Suzuki, Takahiro MD*; Shimoyama, Shinya MD†; Ikeda, Kentaro MD†; Ishii, Yoichiro MD*; Arakawa, Hirokazu MD*

Collapse Box

Abstract

Background: We previously developed a new risk score to predict intravenous immunoglobulin (IVIG) resistance in Kawasaki disease. However, the IVIG dosage used in that study (1 g/kg/d for 2 consecutive days) differs from the single infusion of 2 g/kg recommended in the United States and elsewhere. Our aim was to assess the validity and applicability of our risk score in patients treated with a single infusion.

Methods: We used a database of 1626 patients with Kawasaki disease given initial IVIG treatment at a dose of 1 g/kg/d for 2 consecutive days (n = 990; IVIG- 1 g/kg × 2) or 2 g/kg/d for 1 day (n = 636; IVIG- 2 g/kg × 1) across 17 hospitals in Japan. Patients received the total IVIG dose within 36 hours in IVIG- 1 g/kg × 2 and 24 hours in IVIG- 2 g/kg × 1. We stratified the patients according to a risk scoring system developed to predict IVIG unresponsiveness, based on scores of ≥5 points. We compared the accuracy of prediction between the 2 groups using receiver operating characteristic analysis.

Results: Baseline characteristics and clinical outcomes were similar between both groups. The areas under the receiver operating characteristic curve in IVIG- 2 g/kg × 1 were similar to those of IVIG- 1 g/kg × 2. Using a cut-off risk score of ≥5 points, we could identify IVIG resistance in terms of coronary artery abnormalities within 1 month and coronary artery abnormalities at 1 month with equivalent sensitivity and specificity in both groups.

Conclusion: Our risk score can be used to predict IVIG unresponsiveness to a regimen based on a single infusion of 2 g/kg IVIG.

© 2011 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.